Investor Presentaiton
Aktana-Company Overview
Market Segment:
Headquarters:
COMPANY OVERVIEW
Sales Decision Support / Marketing Automations
(Life Sciences/Medtech)
San Francisco, CA
AKTANA
CEO:
David Ehrlich
• Aktana is an Al-enabled life sciences marketing decision support solution
that helps sales and marketing teams to optimize go-to-market strategies
at the brand level
Helps customers improve their commercial effectiveness by delivering
data-driven insights and suggestions directly to sales reps, coordinating
multi-channel actions, and providing insight regarding which strategies
work best for customers
• Aktana's Decision Support System ("DSE") provides next-best-action
insights for sales reps, while the Learning Platform allows the engine to
learn which suggestions are optimal
Origin:
Capital:
Ownership:
Financing Rounds:
Other Investors:
Board Member:
SUMMARY
June 2016
$14.2M
15% Primary / 13% Fully Diluted
Series B, Series C, Series D
Leerink Transformation Partners, Novartis (dRx),
HLM Venture Partners, Norwest, Starfish Ventures
Eric Salzman
THESIS
• Total addressable market is approximately $2B for pharma and biotech
sales rep decision support
• Focus on the life sciences market has contributed to multi-year growth
rates of more than 100% in relationships with over half of the world's top
15 pharmaceutical companies
• Real-world validation and proven ROI across therapeutic categories and
geographies
• Robust partner ecosystem
• Serves brands across a range of therapeutic areas in multiple geographies
REVENUE MODEL
Aktana prices its platform separately for the decision support engine (DSE)
(aka top layer)-which provides smart suggestions and insights to
pharmaceutical sales representatives within their workflow to help them
make better every day decisions-and the Learning Platform (bottom
layer). For DSE, Aktana licenses the software based on a per rep per brand
basis according to size and number of reps. For the Learning Platform,
Aktana charges an annual fee.
COMPETITORS
Veeva, Salesforce, IQVIA, ZS Associates, Vymo, Customer Insourcing
G
www.safeguard.com
© 2021 Safeguard Scientifics, Inc. All rights reserved.
SFE
LISTED
NYSE
14View entire presentation